Welcome to LookChem.com Sign In|Join Free
  • or

1809249-37-3

Post Buying Request

1809249-37-3 Suppliers

Recommended suppliersmore

Product FOB Price Min.Order Supply Ability Supplier
High purity Coronavirus Inhibitor Remdesivir for covid-2019
Cas No: 1809249-37-3
USD $ 1500.0-1500.0 / Gram 1 Gram 100 Kilogram/Month Nanjing Yuansen Thai Biological Technology Co.,Ltd Contact Supplier
High quality Remdesivir supplier
Cas No: 1809249-37-3
USD $ 100.0-100.0 / Gram 100 Gram 10000 Metric Ton/Day Shanghai Upbio Tech Co.,Ltd Contact Supplier
Remdesivir
Cas No: 1809249-37-3
No Data 1 Gram 10 Kilogram/Week Shanghai Forever Synthesis Co.,Ltd. Contact Supplier
Cheap Remdesivir 1kg in stock
Cas No: 1809249-37-3
No Data 1 Gram Metric Ton/Day Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd Contact Supplier
Remdesivir
Cas No: 1809249-37-3
No Data 1 Gram 1 Kilogram/Month Wuhan MoonZY Biological Technology Co.,Ltd Contact Supplier
Factory High quality Remdesivir(CAS:1809249-37-3)
Cas No: 1809249-37-3
No Data 1 Gram 500 Kilogram/Week Career Henan Chemical Co Contact Supplier
Covid-19 High Purity cas 1809249-37-3 Remdesivir powder
Cas No: 1809249-37-3
No Data 10 Gram 100 Kilogram/Month WUHAN WONDA PHARMACEUTICAL AND CHEMICAL LIMITED Contact Supplier
Remdesivir
Cas No: 1809249-37-3
USD $ 1.0-1.0 / Gram 1 Gram 100g Gram/Week SHANGHAI SYSTEAM BIOCHEM CO., LTD Contact Supplier
High quality Remdesivir in our company 1809249-37-3
Cas No: 1809249-37-3
No Data 10 Gram 1000 Kilogram/Month Shijiazhuang Hangyu Trading Co., Ltd. Contact Supplier
Remdesivir
Cas No: 1809249-37-3
No Data 1 Kilogram 1 Metric Ton/Day Zibo dorne chemical technology co. LTD Contact Supplier

1809249-37-3 Usage

Product Description:

Novel inhibitor of the replication of several taxonomically diverse RNA viruses such as Middle East respiratory syndrome virus, Ebola virus, Lassa fever virus, Junin virus and respiratory syncytial virus, while having low cytotoxicity in a wide-range of cell lines

Remdesivir Properties

Background Information

Remdesivir is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for ARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. 
Remdesivir, also known as GS-5734, is an antiviral drug, a novel nucleotide analog prodrug. It was developed by Gilead Sciences as a treatment for filovirus infections such as Ebola virus disease and Marburg virus, though it has subsequently also been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis, eventually being used in at least one human patient despite its early development stage at the time. Preliminary results have been promising, and further clinical trials are planned.
GS-5734 (Remdesivir) is a monophosphoramidate prodrug of adenosine analogue that exhibits antiviral activity against multiple variants of EBOV (EC50=70-140 nM) and other filoviruses (EC50=0.019-1.48 uM) in cell-based assays; suppresses EBOV replication and protects 100% of EBOV-infected animals against lethal disease, ameliorating clinical disease signs and pathophysiological markers.

Please post your buying leads,so that our qualified suppliers will soon contact you!

*Required Fields